A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
Conditions
- Hyperphosphatemia
- Chronic Kidney Disease, Receiving Dialysis
- ESRD (End-Stage Renal Disease)
- Dialysis
Interventions
- DRUG: AP301
- DRUG: AP301 Low Dose
Sponsor
Alebund Pharmaceuticals
Collaborators